Screening for Type 2 Diabetes Mellitus
Authors: Shelley Selph, Ian Blazina, Roger Chou
Journal: Annals of Internal Medicine (2015)

Letters3 November 2015Screening for Type 2 Diabetes MellitusShelley Selph, MD, MPH, Ian Blazina, MPH, and Roger Chou, MDShelley Selph, MD, MPHFrom Pacific Northwest Evidence-based Practice Center and Oregon Health & Science University, Portland, Oregon.Search for more papers by this author, Ian Blazina, MPHFrom Pacific Northwest Evidence-based Practice Center and Oregon Health & Science University, Portland, Oregon.Search for more papers by this author, and Roger Chou, MDFrom Pacific Northwest Evidence-based Practice Center and Oregon Health & Science University, Portland, Oregon.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/L15-5153-2 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Our review used rigorous methods and a structured approach to evaluate the effectiveness of screening asymptomatic persons for diabetes to improve health outcomes. Evaluating the appropriateness of treatment in persons diagnosed with diabetes because of the presence of symptoms was outside the scope of our review. In order to better understand the risks and benefits of screening, we evaluated direct evidence on benefits and harms of screening as well as indirect evidence, including effects of treatment of screen-detected and early diabetes and of more-intensive versus less-intensive treatments.As described in our results, we found that treatment for impaired ...References1. Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, Sargeant LA, Williams KM, Prevost AT, et al. Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet. 2012;380:1741-8. [PMID: 23040422] doi:10.1016/S0140-6736(12)61422-6 CrossrefMedlineGoogle Scholar2. Li G, Zhang P, Wang J, An Y, Gong Q, Gregg EW, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study. Lancet Diabetes Endocrinol. 2014;2:474-80. [PMID: 24731674] doi:10.1016/S2213-8587(14)70057-9 CrossrefMedlineGoogle Scholar3. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288:321-33. [PMID: 12117397] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAuthors: Shelley Selph, MD, MPH; Ian Blazina, MPH; Roger Chou, MDAffiliations: From Pacific Northwest Evidence-based Practice Center and Oregon Health & Science University, Portland, Oregon.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M14-2221. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoScreening for Type 2 Diabetes Mellitus: A Systematic Review for the U.S. Preventive Services Task Force Shelley Selph , Tracy Dana , Ian Blazina , Christina Bougatsos , Hetal Patel , and Roger Chou Screening for Type 2 Diabetes Mellitus Ebrahim Barkoudah and Larry A. Weinrauch Screening for Type 2 Diabetes Mellitus Ebrahim Barkoudah and Larry A. Weinrauch Metrics Cited bymeliorative effects of Pergamum harmala seed extract on obese diabetic ratsNew onset diabetes in adulthood is associated with a substantial risk for mortality at all ages: a population based historical cohort study with a decade-long follow-upA variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients 3 November 2015Volume 163, Issue 9Page: 726-727KeywordsDisclosureEpidemiologyGlucoseGlucose intoleranceMortalityObservational studiesPopulation statisticsRandomized trialsRenal failureType 2 diabetes ePublished: 3 November 2015 Issue Published: 3 November 2015 Copyright & PermissionsCopyright © 2015 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...